Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 35

Sort by

Sort Order Select

Journal Articles

Outcome of Elderly Patients after Failure to Hypomethylating Agents Given As Frontline Therapy for Acute Myeloid Leukemia (AML): Single Institution Experience

Rama Nanah, MD, Kristen B. McCullough, PharmD, William J Hogan, MBChB, Kebede H. Begna, MD, Naseema Gangat, MBBS, Mrinal M Patnaik, MBBS, Michelle Ann Elliott, MB, BCh, Mark Litzow, MD, Aref Al-Kali, MD

Blood (2016) 128 (22): 1617.

https://doi.org/10.1182/blood.V128.22.1617.1617

Published: 2016

Journal Articles

Clinical Features and Outcomes of Isolated Myeloid Sarcoma in the United States: Analysis Using a National Dataset

Gaurav Goyal, MBBS, Adam C Bartley, MS, Aref Al-Kali, MD, William J Hogan, MBChB, Mark Litzow, MD, Ronald S. Go, MD

Blood (2016) 128 (22): 1618.

https://doi.org/10.1182/blood.V128.22.1618.1618

Published: 2016

Journal Articles

Momelotinib Therapy in Myelofibrosis: 6-Years Follow-up Data on Safety, Efficacy and the Impact of Mutations on Overall and Relapse-Free Survival

Ayalew Tefferi, MD, Daniela Barraco, MD, Terra L. Lasho, PhD, Kebede H. Begna, MD, Aref Al-Kali, MD, William J. Hogan, MBChB, Mark R Litzow, MD, Curtis A. Hanson, MD, Rhett P. Ketterling, MD, Naseema Gangat, MBBS, Animesh Pardanani, MBBS, PhD

Blood (2016) 128 (22): 1123.

https://doi.org/10.1182/blood.V128.22.1123.1123

Published: 2016

Journal Articles

Safety and Efficacy of Fecal Microbiota Transplantation for Recurrent Clostridium Infection in Patients with Hematologic Malignancies

Mehrdad Hefazi, MD, Mrinal M Patnaik, MBBS, William J Hogan, MBChB, Mark R Litzow, MD, Darrell S Pardi, MD, Sahil Khanna, MBBS

Blood (2016) 128 (22): 3599.

https://doi.org/10.1182/blood.V128.22.3599.3599

Published: 2016

Journal Articles

Outcome of Myelodysplastic Syndromes over Time in the US: A National Cancer Data Base Study from 2004-2013

Aref Al-Kali, MD, Darci Zblewski, CNP, Adam C Bartley, MS, Mrinal M Patnaik, MBBS, Naseema Gangat, MBBS, Kebede H. Begna, MD, Ayalew Tefferi, MD, Michelle Elliott, MD, William J Hogan, MBChB, Mark R. Litzow, MD, Ronald S. Go, MD

Blood (2016) 128 (22): 3604.

https://doi.org/10.1182/blood.V128.22.3604.3604

Published: 2016

Journal Articles

Bortezomib, Melphalan and Low Dose TBI Conditioning for Patients Undergoing Autologous Stem Cell Transplantation for Multiple Myeloma

Francis K Buadi, MD, Morie A. Gertz, MD, Betsy R. Laplant, MS, Alese Halvorson, Martha Q. Lacy, MD, Suzanne R. Hayman, MD, David Dingli, MD PhD FRCP, Prashant Kapoor, MD, Wilson I Gonsalves, MD, Teresa Miceli, RN, Eva Brandes, RN, Scott L Stafford, MD, James A Martenson, MD, William J Hogan, MBChB, Shaji K. Kumar, MD

Blood (2016) 128 (22): 2267.

https://doi.org/10.1182/blood.V128.22.2267.2267

Published: 2016

Journal Articles

A Risk Stratification Model Using Quantification of Circulating Plasma Cells in Multiple Myeloma Prior to Autologous Stem Cell Transplantation in the Era of Novel Agents

Rajshekhar Chakraborty, MBBS, Eli Muchtar, MD, Shaji Kumar, MD, Dragan Jevremovic, MD PhD, Francis K Buadi, MD, David Dingli, MD PhD FRCP, Angela Dispenzieri, MD, Suzanne R. Hayman, MD, William J Hogan, MBChB, Prashant Kapoor, MD, Martha Q. Lacy, MD, Nelson Leung, MD, Morie A. Gertz, MD MACP

Blood (2016) 128 (22): 996.

https://doi.org/10.1182/blood.V128.22.996.996

Published: 2016

Journal Articles

Clinical Spectrum of Germline Mutations with Predisposition to Myeloid Neoplasms- 2016 World Health Organization Classification Update

Thanh Ho, MD, Juliana Perez Botero, MD, William J Hogan, MBChB, Saad S Kenderian, MD, Naseema Gangat, MBBS, Ayalew Tefferi, MD, Roshini S Abraham, PhD, Phuong L. Nguyen, MD, Jennifer L Oliveira, MD, Rong He, MD, Dong Chen, MD PhD, David Viswanatha, MD, Vilmarie Rodriguez, MD, Shakila Khan, MD, Mrinal M Patnaik, MBBS

Blood (2016) 128 (22): 300.

https://doi.org/10.1182/blood.V128.22.300.300

Published: 2016

Journal Articles

Clinical Outcomes Related to the Use of Monoclonal Antibody Therapy for Steroid Refractory Acute Graft-Versus Host Disease after Allogeneic Hematopoietic Cell Transplantation

Fevzi Yalniz, MD, Mehrdad Hefazi, MD, Kristen B. McCullough, PharmD, Mark Litzow, MD, William J Hogan, MBChB, Robert C Wolf, PharmD, Hassan B Alkhateeb, MD, Ankit Kansagra, Moussab Damlaj, MD, Mrinal M Patnaik, MBBS

Blood (2016) 128 (22): 4593.

https://doi.org/10.1182/blood.V128.22.4593.4593

Published: 2016

Journal Articles

Day +30 and Day +100 CD33 Chimerisms Predict Survival after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Myelofibrosis

Tania Jain, M.B.,B.S, M'hamed Temkit, Daniel K. Partain, MD, Mrinal M Patnaik, MBBS, James L. Slack, MD, Nandita Khera, MD, William J. Hogan, MBChB, Vivek Roy, MD, Pierre Noel, MD, Jose F Leis, MD PhD, Lisa Sproat, MD MSW, Veena DS Fauble, MD, Ruben A. Mesa, MD, Jeanne Palmer, MD

Blood (2016) 128 (22): 4653.

https://doi.org/10.1182/blood.V128.22.4653.4653

Published: 2016

Journal Articles

Myeloid Sarcoma: The Mayo Clinic Experience of Ninety Six Case Series

Jennifer Yui, MD, Mythri Mudireddy, MBBS, Mrinal M Patnaik, MBBS, Naseema Gangat, MBBS, Aref Al-Kali, MD, Michelle Elliott, MD, William J. Hogan, MBChB, C. Christopher Hook, MD, Alexandra P Wolanskyj, MD, Mark R. Litzow, MD, Matthew T Howard, MD, Curtis A. Hanson, MD, Rhett P. Ketterling, MD, Animesh D. Pardanani, MBBS, PhD, Ayalew Tefferi, MD, Kebede H. Begna, MD

Blood (2016) 128 (22): 2798.

https://doi.org/10.1182/blood.V128.22.2798.2798

Published: 2016

Journal Articles

Deficiency of Current Acute Myeloid Leukemia (AML) Response Criteria to Predict Response to Hypomethylating Agent Therapy: The Value of Long-Lasting Stable Disease

Stephanie Williams, MD, Rama Nanah, MD, Darci Zblewski, CNP, Michelle Elliott, MD, William J. Hogan, MBChB, Raoul Tibes, MD PhD, James M. Foran, MD, Mark R. Litzow, MD, Aref Al-Kali, MD

Blood (2016) 128 (22): 2799.

https://doi.org/10.1182/blood.V128.22.2799.2799

Published: 2016

Journal Articles

Fludarabine Busulfan Compared to Fludarabine Melphalan Is Associated with Increased Relapse Risk in Reduced Intensity Conditioning Transplant Despite Pharmacokinetic Dosing

Moussab Damlaj, MD, Hassan B Alkhateeb, MD, Daniel K. Partain, MD, Jehad Almasri, MD, Mehrdad Hefazi, MD, Shahrukh K. Hashmi, MD, Dennis A. Gastineau, MD, Aref Al-Kali, MD, Robert C Wolf, PharmD, Naseema Gangat, MBBS, Mark R Litzow, MD, William J Hogan, MBChB, Mrinal M Patnaik, MBBS

Blood (2015) 126 (23): 736.

https://doi.org/10.1182/blood.V126.23.736.736

Published: 2015

Journal Articles

The Role of Spleen Directed Therapy and Predictors of Outcomes with Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Primary Myelofibrosis and Splenomegaly

Daniel K. Partain, MD, Moussab Damlaj, MD, Aref Al-Kali, MD, Naseema Gangat, MBBS, Mark R Litzow, MD, William J Hogan, MBChB, Shahrukh K. Hashmi, MD, Wilson I. Gonsalves, MD, James M. Foran, MD, Vivek Roy, MD FACP, Ruben A. Mesa, Jeanne Palmer, MD, James L. Slack, MD, Mrinal M Patnaik, MBBS

Blood (2015) 126 (23): 4370.

https://doi.org/10.1182/blood.V126.23.4370.4370

Published: 2015

Journal Articles

A Single Institution Study of Allogeneic Hematopoietic Stem Cell Transplant for MDS and AML in Patients 60 Years of Age and Older: Impact of Disease Risk Index and Secondary Disease

Eva Gupta, MD, Randi Hoffman, Thomas Colleen, MS, William J Hogan, MBChB, Mark R Litzow, MD, Lisa Sproat, MD MSW, James M. Foran, MD, Laura E. Finn, MD, Vivek Roy, MD

Blood (2015) 126 (23): 5532.

https://doi.org/10.1182/blood.V126.23.5532.5532

Published: 2015

Journal Articles

Novel Genetic Variants in Complement-Mediated Thrombotic Microangiopath

Blood (2015) 126 (23): 1050.

https://doi.org/10.1182/blood.V126.23.1050.1050

Published: 2015

Journal Articles

Clinical Outcome of Therapy-Related Acute Myeloid Leukemia Is Strongly Related to Cytogenetic Analysis

Croix Fossum, BS, Rhett P. Ketterling, MD, Lindsey E. Roeker, Ajoy L. Dias, MD, Michelle Elliott, MD, William J. Hogan, MBChB, Mark R. Litzow, MD, Aref Al-Kali, MD

Blood (2015) 126 (23): 1401.

https://doi.org/10.1182/blood.V126.23.1401.1401

Published: 2015

Journal Articles

Early T-Lymphocyte Chimerism Kinetics Is Influenced By Conditioning Regimen in Reduced Intensity Allogeneic Stem Cell Transplantation

Nosha Farhadfar, MD, Damlaj Moussab, MD, Ajoy L. Dias, MD, Hassan B Alkhateeb, MD, Mark R Litzow, MD, Shahrukh K. Hashmi, MD, Mrinal M Patnaik, MBBS, William J Hogan, MBChB

Blood (2015) 126 (23): 1923.

https://doi.org/10.1182/blood.V126.23.1923.1923

Published: 2015

Journal Articles

Prognostic Impact of Peripheral Blood Count Recovery and Cytogenetic Remission Prior to Reduced Intensity Allogeneic Transplantation in Patients with Acute Myelogenous Leukemia and Myelodysplastic Syndromes

Moussab Damlaj, MD, Hassan B Alkhateeb, MD, Mehrdad Hefazi, MD, Daniel K. Partain, MD, Aref Al-Kali, MD, Shahrukh K. Hashmi, MD, Naseema Gangat, MBBS, Mark R Litzow, MD, William J Hogan, MBChB, Mrinal M Patnaik, MBBS

Blood (2015) 126 (23): 3210.

https://doi.org/10.1182/blood.V126.23.3210.3210

Published: 2015

Journal Articles

The Adverse Impact of Age and Central Nervous System Involvement on Survival in Adult T-ALL, an Analysis of 92 Consecutive Patients

Hassan B Alkhateeb, MD, Moussab Damlaj, MD, Tasha Lin, MD, Mehrdad Hefazi, MD, Aref Al-Kali, MD, Naseema Gangat, MBBS, William J. Hogan, MBChB, Michelle Elliott, MD, Grzegorz S. Nowakowski, MD, Carrie Thompson, MD, Thomas E. Witzig, MD, Stephen M Ansell, MD, PhD, Mark R Litzow, MD, Mrinal M Patnaik, MBBS

Blood (2015) 126 (23): 4993.

https://doi.org/10.1182/blood.V126.23.4993.4993

Published: 2015

NARROW

Outcome of Elderly Patients after Failure to Hypomethylating Agents Given As Frontline Therapy for Acute Myeloid Leukemia (AML): Single Institution Experience

Clinical Features and Outcomes of Isolated Myeloid Sarcoma in the United States: Analysis Using a National Dataset

Momelotinib Therapy in Myelofibrosis: 6-Years Follow-up Data on Safety, Efficacy and the Impact of Mutations on Overall and Relapse-Free Survival

Safety and Efficacy of Fecal Microbiota Transplantation for Recurrent Clostridium Infection in Patients with Hematologic Malignancies

Outcome of Myelodysplastic Syndromes over Time in the US: A National Cancer Data Base Study from 2004-2013

Bortezomib, Melphalan and Low Dose TBI Conditioning for Patients Undergoing Autologous Stem Cell Transplantation for Multiple Myeloma

A Risk Stratification Model Using Quantification of Circulating Plasma Cells in Multiple Myeloma Prior to Autologous Stem Cell Transplantation in the Era of Novel Agents

Clinical Spectrum of Germline Mutations with Predisposition to Myeloid Neoplasms- 2016 World Health Organization Classification Update

Clinical Outcomes Related to the Use of Monoclonal Antibody Therapy for Steroid Refractory Acute Graft-Versus Host Disease after Allogeneic Hematopoietic Cell Transplantation

Day +30 and Day +100 CD33 Chimerisms Predict Survival after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Myelofibrosis

Myeloid Sarcoma: The Mayo Clinic Experience of Ninety Six Case Series

Deficiency of Current Acute Myeloid Leukemia (AML) Response Criteria to Predict Response to Hypomethylating Agent Therapy: The Value of Long-Lasting Stable Disease

Fludarabine Busulfan Compared to Fludarabine Melphalan Is Associated with Increased Relapse Risk in Reduced Intensity Conditioning Transplant Despite Pharmacokinetic Dosing

The Role of Spleen Directed Therapy and Predictors of Outcomes with Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Primary Myelofibrosis and Splenomegaly

A Single Institution Study of Allogeneic Hematopoietic Stem Cell Transplant for MDS and AML in Patients 60 Years of Age and Older: Impact of Disease Risk Index and Secondary Disease

Novel Genetic Variants in Complement-Mediated Thrombotic Microangiopath

Clinical Outcome of Therapy-Related Acute Myeloid Leukemia Is Strongly Related to Cytogenetic Analysis

Early T-Lymphocyte Chimerism Kinetics Is Influenced By Conditioning Regimen in Reduced Intensity Allogeneic Stem Cell Transplantation

Prognostic Impact of Peripheral Blood Count Recovery and Cytogenetic Remission Prior to Reduced Intensity Allogeneic Transplantation in Patients with Acute Myelogenous Leukemia and Myelodysplastic Syndromes

The Adverse Impact of Age and Central Nervous System Involvement on Survival in Adult T-ALL, an Analysis of 92 Consecutive Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only